Cargando…
Structural Asymmetry of Phosphodiesterase-9, Potential Protonation of a Glutamic Acid, and Role of the Invariant Glutamine
PDE9 inhibitors show potential for treatment of diseases such as diabetes. To help with discovery of PDE9 inhibitors, we performed mutagenesis, kinetic, crystallographic, and molecular dynamics analyses on the active site residues of Gln453 and its stabilizing partner Glu406. The crystal structures...
Autores principales: | Hou, Jing, Xu, Jie, Liu, Ming, Zhao, Ruizhi, Luo, Hai-Bin, Ke, Hengming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069055/ https://www.ncbi.nlm.nih.gov/pubmed/21483814 http://dx.doi.org/10.1371/journal.pone.0018092 |
Ejemplares similares
-
Discovery of a Phosphodiesterase
9A Inhibitor as a Potential Hypoglycemic Agent
por: Shao, Yong-xian, et al.
Publicado: (2014) -
Glutamine and glutamate: Nonessential or essential amino acids?
por: Watford, Malcolm
Publicado: (2015) -
Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study
por: Maltezos, S, et al.
Publicado: (2014) -
Modeling the glutamate–glutamine neurotransmitter cycle
por: Shen, Jun
Publicado: (2013) -
Glutamine and glutamate supplementation raise milk glutamine concentrations in lactating gilts
por: Manso, Helena Emilia CCC, et al.
Publicado: (2012)